These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9334450)

  • 1. [Clinical and hematological changes in calves infected with Anaplasma marginale].
    Alfonso J; Medina R; Fazzino F; Caballero H
    Acta Cient Venez; 1996; 47(1):50-7. PubMed ID: 9334450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new long-acting oxytetracycline formulation against anaplasmosis in colombian cattle.
    Todorovic RA; Gonzalez EF; Garcia O
    Tropenmed Parasitol; 1979 Jun; 30(2):236-8. PubMed ID: 483386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of a short and a long acting oxytetracycline for the treatment of Anaplasma marginale in splenectomized calves.
    Stewart CG; Immelman A; Grimbeek P; Grib D
    J S Afr Vet Assoc; 1979 Jun; 50(2):83-5. PubMed ID: 551196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD; Eckblad WP; Magonigle RA
    Am J Vet Res; 1982 Aug; 43(8):1360-2. PubMed ID: 7103219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of bovines using a DNA vaccine (pcDNA3.1/MSP1b) prepared from the Jaboticabal strain of Anaplasma marginale.
    de Andrade GM; Machado RZ; Vidotto MC; Vidotto O
    Ann N Y Acad Sci; 2004 Oct; 1026():257-66. PubMed ID: 15604503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline.
    Roby TO; Simpson JE; Amerault TE
    Am J Vet Res; 1978 Jul; 39(7):1115-6. PubMed ID: 677530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic alterations of Anaplasma marginale in calves after treatment with oxytetracycline.
    Simpson CF
    Am J Vet Res; 1975 Oct; 36(10):1443-6. PubMed ID: 1190584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical chemistry of anaplasmosis: comparative serum protein changes elicited by attenuated and virulent Anaplasma marginale isolates.
    Allen PC; Kuttler KL; Amerault TE
    Am J Vet Res; 1981 Feb; 42(2):326-8. PubMed ID: 7258784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of enrofloxacin against severe experimental Anaplasma marginale infections in splenectomized calves.
    Coetzee JF; Apley MD
    Vet Ther; 2006; 7(3):319-28. PubMed ID: 17039454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural and fluorochromatic changes of Anaplasma marginale exposed to oxytetracycline, imidocarb and enrofloxacin in short-term erythrocyte cultures.
    Coetzee JF; Kocan KM; Higgins JJ; Apley MD; Jones DE
    Vet Microbiol; 2009 Apr; 136(1-2):45-53. PubMed ID: 19054634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle.
    Kuttler KL
    Am J Vet Res; 1983 May; 44(5):882-3. PubMed ID: 6869997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL; Thomas GM
    J Am Vet Med Assoc; 1983 Jul; 183(1):63-5. PubMed ID: 6874524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine anaplasmosis: in utero transmission and the immunologic significance of ingested colostral antibodies.
    Zaugg JL; Kuttler KL
    Am J Vet Res; 1984 Mar; 45(3):440-3. PubMed ID: 6711971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant infection of cattle with the vaccine strain Anaplasma marginale ss centrale and field strains of A. marginale.
    Shkap V; Leibovitz B; Krigel Y; Molad T; Fish L; Mazuz M; Fleiderovitz L; Savitsky I
    Vet Microbiol; 2008 Aug; 130(3-4):277-84. PubMed ID: 18387757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative efficacy of two oxytetracycline formulations and doxycycline in the treatment of acute anaplasmosis in splenectomized calves.
    Kuttler KL; Simpson JE
    Am J Vet Res; 1978 Feb; 39(2):347-9. PubMed ID: 629473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of sequential coinfection with Anaplasma phagocytophilum and Anaplasma marginale in cattle.
    Hoar BR; Nieto NC; Rhodes DM; Foley JE
    Am J Vet Res; 2008 Sep; 69(9):1171-8. PubMed ID: 18764690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of enrofloxacin, imidocarb, and oxytetracycline for clearance of persistent Anaplasma marginale infections in cattle.
    Coetzee JF; Apley MD; Kocan KM
    Vet Ther; 2006; 7(4):347-60. PubMed ID: 17216590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical chemistry of anaplasmosis: blood chemical changes in infected mature cows.
    Allen PC; Kuttler KL; Amerault TE
    Am J Vet Res; 1981 Feb; 42(2):322-5. PubMed ID: 7258783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric evaluation of selected antimicrobial efficacy for clearance of Anaplasma marginale in short-term erythrocyte cultures.
    Coetzee JF; Apley MD; Kocan KM; Jones DE
    J Vet Pharmacol Ther; 2006 Jun; 29(3):173-83. PubMed ID: 16669861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.